Capricor Therapeutics (CAPR) Q2 2025 Earnings

May 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.53
-0.41
-0.28
-0.16

Details

Expected EPS
-0.316667
Actual EPS
-0.53
Surprise EPS
-0.21
Surprise Percent
-67.37%

Description

⁨Capricor Therapeutics⁩ (⁦CAPR⁩) has reported earnings of ⁦-0.53⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts